-
Alexion and Sema4 partner in rare disease diagnostics
pharmatimes
August 14, 2017
Alexion has partnered with Sema4 to leverage their shared experience in data science and systems biology to accelerate rare disease diagnosis and therapeutic discovery.
-
£2m UK consortium to tackle gene therapy
pharmatimes
August 14, 2017
A new consortium, led by Oxford BioMedica, will embark on a two-year, £2 million project focused on gene and cell therapy manufacturing.
-
UK Biobank releases genetic data on 0.5m people
europeanpharmaceuticalreview
July 31, 2017
Genetic data on half a million people was made available for research last week by the UK Biobank study.
-
Sema4 announces the launch of CarrierCheck
biospectrumasia
July 26, 2017
CarrierCheck stands apart in providing individuals with an online ordering pathway to a genetic test with easy-to-understand results that can reveal an individual's probability of being a carrier for any of the 67 hereditary conditions.
-
Gene variant protecting against Alzheimer’s decreases plasma beta-amyloid levels
expressbpd
June 21, 2017
The METSIM data comprises 10,000 men living in the eastern part of Finland and the findings were published in Annals of Neurology
-
New NIH study reveals mutations in gene CABLES1 may lead to Cushing syndrome
pharmaceutical-technology
June 06, 2017
A new study conducted by researchers at the National Institutes of Health (NIH) shows that mutations in the gene CABLES1 may lead to Cushing syndrome, a rare disorder that makes the human body produce excess stress hormone cortisol.